InvestorsHub Logo
icon url

HiddenGem69

09/30/13 9:41 AM

#1212869 RE: HiddenGem69 #1212808

$NVLX After presenting the results of its large scale Phase III clinical trial at the 2013 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology in late January, the U.S. Food and Drug Administration (FDA) moved quickly to approve Celgene Corp.'s ABRAXANE® when used in combination with gemcitabine.